SET/TAF-I 抗体 (AbBy Fluor® 488)
Quick Overview for SET/TAF-I 抗体 (AbBy Fluor® 488) (ABIN915028)
抗原
See all SET/TAF-I (SET) 抗体适用
宿主
克隆类型
标记
应用范围
-
-
交叉反应
- 人
-
预测反应
- Mouse,Rat,Dog,Cow,Horse,Chicken,Rabbit
-
纯化方法
- Purified by Protein A.
-
免疫原
- KLH conjugated synthetic peptide derived from human SET
-
亚型
- IgG
-
-
-
-
应用备注
-
FCM: 1:20-100, IF(IHC-P): 1:50-200
Optimal working dilution should be determined by the investigator. -
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1 mg/mL
-
缓冲液
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- -20 °C
-
储存方法
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
有效期
- 12 months
-
-
- SET/TAF-I (SET) (SET Nuclear Oncogene (SET))
-
别名
- Set
-
背景
- Optional[synonyms]: SET_HUMAN, Protein SET, HLA-DR-associated protein II, Inhibitor of granzyme A-activated DNase (IGAAD), PHAPII, Phosphatase 2A inhibitor I2PP2A (I-2PP2A), Template-activating factor I (TAF-I), 2PP2A, IGAAD, MRD58, TAF-I, I2PP2A, IPP2A2, PHAPII, TAF-IBETA,
-
基因ID
- 6418
-
UniProt
- Q01105
-
途径
- Apoptosis
抗原
-